Cardiomyopathy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 or older at the time of signing the consent form to take part in the study
- People who have been diagnosed with ATTR cardiomyopathy (a heart condition caused by a protein called amyloid building up in the heart), as defined by the trial's criteria
- People who are able to give written, signed, and dated consent to participate before any study-related activities begin
- People who are willing and able to follow all study procedures and requirements throughout the trial
- People who are currently a patient at one of the participating study sites (called a NAC site)
Who may not be able to join:
- People who are unable to use or do not have access to a BodyTrace smart scale device at their usual home address (for example, if there is no mobile network signal available there)
- People who are on dialysis or have very severely reduced kidney function (confirm with trial site)
- People with a very low level of a blood protein called albumin, or who have tissue swelling caused by a condition other than fluid overload — such as certain bowel or kidney conditions (confirm with trial site)
- People who are currently taking more than two types of water tablets (diuretics) by mouth, such as those already on the maximum oral diuretic treatment
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Tamer Rezk, MBBS MRCP PhD, National Amyloidosis Centre, Royal Free Hospital
Phone: +44 02070425800
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Heart-failure related hospitalisations; All-cause mortality
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.